895 related articles for article (PubMed ID: 20535121)
1. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
[TBL] [Abstract][Full Text] [Related]
2. Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia.
Halmos A; Rigó J; Szijártó J; Füst G; Prohászka Z; Molvarec A
Clin Exp Immunol; 2012 Jul; 169(1):49-56. PubMed ID: 22670778
[TBL] [Abstract][Full Text] [Related]
3. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
4. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia.
Stenczer B; Molvarec A; Veresh Z; Gullai N; Nagy GR; Walentin S; Szijártó J; Rigó J
Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1291-5. PubMed ID: 21682699
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
9. Plasma sFlt-1-to-PlGF ratio is correlated with inflammatory but not with oxidative stress in Chinese preeclamptic women.
Ouyang YQ; Li SJ; Zhang Q; Xiang WP; Shen HL; Chen HP; Chen H; Chen HZ
Arch Gynecol Obstet; 2009 Jul; 280(1):91-7. PubMed ID: 19099313
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.
Molvarec A; Szarka A; Walentin S; Beko G; Karádi I; Prohászka Z; Rigó J
Reprod Biol Endocrinol; 2011 Sep; 9():124. PubMed ID: 21906313
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.
Ohkuchi A; Hirashima C; Suzuki H; Takahashi K; Yoshida M; Matsubara S; Suzuki M
Hypertens Res; 2010 May; 33(5):422-7. PubMed ID: 20150910
[TBL] [Abstract][Full Text] [Related]
12. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
14. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
[TBL] [Abstract][Full Text] [Related]
15. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
16. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study.
Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA
Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264
[TBL] [Abstract][Full Text] [Related]
17. Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.
Ohkuchi A; Hirashima C; Takahashi K; Suzuki H; Matsubara S; Suzuki M
Hypertens Res; 2013 Dec; 36(12):1073-80. PubMed ID: 23966056
[TBL] [Abstract][Full Text] [Related]
18. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
19. Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia.
Li J; Cai A; Yuan Q; Ding H; Zhao D
Int J Gynaecol Obstet; 2019 May; 145(2):176-181. PubMed ID: 30801711
[TBL] [Abstract][Full Text] [Related]
20. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]